This work has focused on the development and validation of a computational tool that will be fundamental in our next studies aimed at understanding the pathogenesis and molecular mechanisms of neurodegenerative diseases that trigger chemical changes in the tau protein. The gene discussed is MAPT; the disease is neurodegenerative disease.